This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

8 Stocks Rising on Unusual Volume

NEW YORK ( Stockpickr) -- Professional traders don't just look at a stock's price moves; they also look for big changes in volume.

Major moves in volume can signal unusual activity, such as insider buying or selling -- or buying or selling by "superinvestors."

Let's take a look at several stocks rising on unusual volume today. In today's trading, these stocks are all already recording volume that is 87% or more above their average trading volume for a full day.

>>5 Technical Setups to Ride This Rally

United Therapeutics (UTHR) is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer. The stock is trading up 1% at $40.14 in recent trading.

Volume: 5.2 million

Average Volume: 1.6 million

Volume % Change: 220.4%

On Tuesday, United Therapeutics announced plans to offer $210 million in senior notes and to buy back up to $212 million worth of stock.

The stock is one of the top holdings of Steven Cohen's SAC Capital as of the most recently reported period.

Liz Claiborne (LIZ) and its subsidiaries are engaged mainly in the design and marketing of a global portfolio of retail-based premium brands, including Juicy Couture and Kate Spade. The stock is trading up 32.6% at $6.76 in recent trading.

Volume: 15.1 million

Average Volume: 3.5 million

Volume % Change: 320.8%

On Wednesday, Liz Claiborne announced plans to sell several brands for $328 million -- including its namesake brand, which will go to J.C. Penney (JCP) -- to focus on higher-end brands such as Kate Spade and Juicy Couture. The company will also change its name.

Onyx Pharmaceuticals (ONXX) is a biopharmaceutical company is engaged in the development of innovative therapies that target the molecular mechanisms that cause cancer. The stock is trading up 6% at $33.81 in recent trading.

Volume: 2.8 million

Average Volume: 901,600

Volume % Change: 214.8%

On Wednesday, Onyx and Bayer a settlement in the lawsuit over the development and marketing of the cancer drug regorafenib in which Onyx will receive 20% royalty from Bayer on worldwide sales of the drug.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs